Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A world without measles.

Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, Katz SL.

J Infect Dis. 2011 Jul;204 Suppl 1:S1-3. doi: 10.1093/infdis/jir111. No abstract available.

2.

Global eradication of measles: an epidemiologic and economic evaluation.

Levin A, Burgess C, Garrison LP Jr, Bauch C, Babigumira J, Simons E, Dabbagh A.

J Infect Dis. 2011 Jul;204 Suppl 1:S98-106. doi: 10.1093/infdis/jir096.

3.

Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008.

van den Ent MM, Brown DW, Hoekstra EJ, Christie A, Cochi SL.

J Infect Dis. 2011 Jul;204 Suppl 1:S18-23. doi: 10.1093/infdis/jir081.

4.

Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update.

Cairns KL, Perry RT, Ryman TK, Nandy RK, Grais RF.

J Infect Dis. 2011 Jul;204 Suppl 1:S35-46. doi: 10.1093/infdis/jir072. Review.

5.

Progress toward global measles control and regional elimination, 1990-1997.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1998 Dec 11;47(48):1049-54.

6.

Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.

Babigumira JB, Levin A, Burgess C, Garrison LP Jr, Bauch CT, Braka F, Mbabazi WB, Nabyonga JO, Simons E, Dabbagh A.

J Infect Dis. 2011 Jul;204 Suppl 1:S116-23. doi: 10.1093/infdis/jir132.

7.

Impact of measles elimination activities on immunization services and health systems: findings from six countries.

Hanvoravongchai P, Mounier-Jack S, Oliveira Cruz V, Balabanova D, Biellik R, Kitaw Y, Koehlmoos T, Loureiro S, Molla M, Nguyen H, Ongolo-Zogo P, Sadykova U, Sarma H, Teixeira M, Uddin J, Dabbagh A, Griffiths UK.

J Infect Dis. 2011 Jul;204 Suppl 1:S82-9. doi: 10.1093/infdis/jir091.

8.

The measles tragedy revisited.

Tulchinsky TH.

Public Health Rep. 1998 Nov-Dec;113(6):479-80. No abstract available.

9.

Emerging issues in measles.

Obimbo EM.

East Afr Med J. 2001 Jan;78(1):1-3. No abstract available.

PMID:
11320756
10.

Global measles control and regional elimination, 1998-1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Dec 17;48(49):1124-30.

11.

Strategies for reducing global measles mortality.

[No authors listed]

Wkly Epidemiol Rec. 2000 Dec 15;75(50):411-6. English, French. No abstract available.

PMID:
11189704
12.

Global measles deaths plunge by 48% over past six years.

[No authors listed]

Indian J Med Sci. 2006 Mar;60(3):127-9. No abstract available.

PMID:
16622973
13.

Global measles deaths plunge by 48% over past six years.

[No authors listed]

Saudi Med J. 2006 Jun;27(6):918-22. No abstract available.

PMID:
16969955
14.

World eradication of measles.

Hinman AR.

Rev Infect Dis. 1982 Sep-Oct;4(5):933-9.

PMID:
7146730
15.

Measles vaccines: WHO position paper.

[No authors listed]

Wkly Epidemiol Rec. 2009 Aug 28;84(35):349-60. English, French. No abstract available.

16.

Global measles situation.

Ebrahim GJ.

J Trop Pediatr. 2010 Aug;56(4):219-20. doi: 10.1093/tropej/fmq055. Epub 2010 Jul 2. No abstract available.

PMID:
20601377
17.

Strategic planning for measles control: using data to inform optimal vaccination strategies.

Simons E, Mort M, Dabbagh A, Strebel P, Wolfson L.

J Infect Dis. 2011 Jul;204 Suppl 1:S28-34. doi: 10.1093/infdis/jir095.

18.

Measles control and the prospect of eradication.

Moss WJ.

Curr Top Microbiol Immunol. 2009;330:173-89. Review.

PMID:
19203110
19.

Measles vaccination.

Allam MF.

J Prev Med Hyg. 2009 Dec;50(4):201-5. Review. No abstract available.

PMID:
20812514
20.

A Bellagio consensus. Children's Vaccine Initiative Ad Hoc Committe on an Investment Strategy for Measles Control.

[No authors listed]

J Infect Dis. 1994 Nov;170 Suppl 1:S63-6. Review. No abstract available.

PMID:
7930755
Items per page

Supplemental Content

Write to the Help Desk